biotech
BMS’ Opdivo to finally be made available to lung cancer patients in the UK
September 20, 2017Research and Development, Sales and Marketing Bristol-Myers Squibb, NICE, biotech, drugs, opdivo, pharma, pharmaceutical
It is two and a half years since patients with lung cancer in the US were able to receive Bristol-Myers …
GSK gets FDA approval for key triple therapy inhaler
September 20, 2017Research and Development, Sales and Marketing GSK, Trelegy Ellipta, biotech, drugs, pharma, pharmaceutical
The good news keeps on rolling in for GSK, with the FDA approval for its triple therapy inhaler.
FDA locks down combo immunotherapy trials, Roche added to hold
September 19, 2017Manufacturing and Production, Sales and Marketing Roche, biotech, drugs, immunotherapy, pharma, pharmaceutical, tecentriq
The FDA has moved to ensure that all immunotherapy trials studying PD-1/L1 agents, alongside immunomodulatory medicines in certain blood cancers …
Teva completes sale of women’s health for $1.38 billion
September 19, 2017Manufacturing and Production, Sales and Marketing Teva, biotech, drugs, pharma, pharmaceutical, women's health
Teva announced last week that it had reached an agreement to sell Paragard, an intrauterine copper contraceptive, to CooperSurgical for …
Swine flu pandemic linked to increased incidence of diabetes
September 19, 2017Manufacturing and Production, Research and Development biotech, diabetes type 1, drugs, influenza, pharma, pharmaceutical, swine flu
The swine flu pandemic that swept the world in 2009 may have had unforeseen consequences in some populations, after researchers …
Scholar Rock prise Regulatory Affairs director away from Biogen
September 18, 2017Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Scholar Rock, biotech, drugs, pharma, pharmaceutical
Scholar Rock has announced that it has moved to appoint Heather Faulds as Vice President of Regulatory Affairs. Faulds joins …
Standing together: Supercharging the clinical trial in Europe
September 18, 2017Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing EMA, biotech, clinical trials, drugs, pharma, pharmaceutical
The European Medicines Agency is on the cusp of rolling out one of the most ground-breaking digital platforms for facilitating …
FDA approves first medical app, for use in addiction
September 18, 2017Sales and Marketing Pear Therapeutics, biotech, drugs, pharma, pharmaceutical, reset
The FDA has taken a major step in the digitisation of healthcare by handing out the first medical app approval: …
Bayer lymphoma treatment speeds to FDA approval
September 18, 2017Sales and Marketing Aliqopa, Bayer, biotech, drugs, pharma, pharmaceutical
The FDA gave Bayer priority review for its treatment Aliqopa (copanlisib) in May of this year, and it quickly came …
Santhera ‘surprised’ by European rejection of DMD drug
September 18, 2017Sales and Marketing Duchenne Muscular Dystrophy, biotech, drugs, pharma, pharmaceutical, santhera
Santhera Pharmaceutical has announced the EMA’s CHMP rejected its treatment for Duchenne muscular dystrophy (DMD) but revealed that it planned …
Pfizer receives prostate cancer drug boost with trial results
September 15, 2017Medical Communications, Research and Development Astellas, Pfizer, Xtandi, biotech, drugs, pharma, pharmaceutical
Pfizer, and its partner Astellas Pharma, received a major boost to its plans for prostate cancer treatment, Xtandi, by announcing …
GSK receives positive opinion for triple-therapy inhaler
September 15, 2017Medical Communications, Sales and Marketing GSK, biotech, drugs, pharma, pharmaceutical
GSK, alongside its partner Innoviva, has announced that it has received a positive opinion from the EMA’s CHMP for its …
AstraZeneca’s Forxiga displays potential in type 1 diabetes
September 14, 2017Research and Development AstraZeneca, Forxiga, biotech, drugs, farxiga, pharma, pharmaceutical
Forxiga is AstraZeneca’s treatment for those living with type 2 diabetes but the results from a new trial have found …
GDPR and Human Data Samples: Being ‘somewhat prepared’ is not enough
September 14, 2017Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing GDPR, biotech, data, drugs, pharma, pharmaceutical
Thomas Hirse, Partner, and Paetrick Sakowski, Associate, CMS, discuss what pharmaceutical companies need to be aware of ahead of the …
FDA panel gives GSK’s Shingrix unanimous approval
September 14, 2017Sales and Marketing GSK, Shingrix, biotech, drugs, pharma, pharmaceutical, shingles
The FDA’s advisory panel has given a strong signal that GSK’s Shingrix should not have too much difficulty getting full …
Latest content
ESTEVE CDMO adds $17.5m to Illinois expansion
Brenntag and dsm-firmenich expand biopharma vitamin partnership
